Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages
Obesity represents a risk factor for breast cancer development and therapy resistance, but the molecular players underling these links are unclear. Here, we identify a role for the obesity-cytokine leptin in sustaining aromatase inhibitor (AI) resistant growth and progression in breast cancer. Using...
Main Authors: | Luca Gelsomino, Cinzia Giordano, Giusi La Camera, Diego Sisci, Stefania Marsico, Antonella Campana, Roberta Tarallo, Antonio Rinaldi, Suzanne Fuqua, Antonella Leggio, Fedora Grande, Daniela Bonofiglio, Sebastiano Andò, Ines Barone, Stefania Catalano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/4/543 |
Similar Items
-
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression
by: Salvatore Panza, et al.
Published: (2020-06-01) -
Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
by: Sebastiano Andò, et al.
Published: (2019-01-01) -
Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression
by: Luca Gelsomino, et al.
Published: (2020-07-01) -
Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells
by: Giuseppina Augimeri, et al.
Published: (2020-08-01) -
Leptin: A Heavyweight Player in Obesity-Related Cancers
by: Amanda Caruso, et al.
Published: (2023-07-01)